A recent study found that that men who ejaculated more often had lower incidents of prostate cancer than those who got off less often.
Improper functioning of the mitochondria may help account for the fact that african-american men with prostate cancer respond poorly to conventional chemotherapy
Sanofi said that it first privately made an offer to acquire the prostate cancer drug maker nearly two weeks ago but had not received a response to its offer.
University Hospitals Seidman Cancer Center physicians have started the world's first clinical trial using a new form of stereotactic body radiotherapy (SBRT) to deliver radiation to a specific area of the prostate invaded with cancer - instead of the entire gland.
Urologists at University of California, San Diego School of Medicine and Genesis Healthcare Partners have tested a new model of care for patients with low-risk prostate cancer. The evidence-based approach uses best practices to appropriately select and follow patients to avoid disease overtreatment. Show More Summary
A novel function of the gene PLK1 (polo-like kinase 1) has been uncovered that helps prostate cancer cells metastasize (spread) to other parts of the body. This mechanism highlights new potential targets for cancer therapies and challenges the previous understanding of PLK1’s role in cancer growth and progression.
Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps prostate cancer cells metastasize (spread) to other parts of the body. This mechanism highlights new potential targets for cancer therapies and challenges the previous understanding of PLK1's role in cancer growth and progression.
A study focused on men affected by prostate cancer may offer all couples some help on heating things up in the bedroom. The post Can Exercising as a Couple Increase Sexual Intimacy? appeared first on The Good Men Project.
Traditional approaches to tackling prostate cancer are generally quite effective, with a 80 to 90 percent cure rate, but a new method, known as Stereotactic Body Radiation Therapy (SBRT) could revolutionize the practice. The resultsShow More Summary
A link between higher intake of dietary saturated fat, a type of fat found commonly in foods such as fatty beef and cheese, and risk of aggressive prostate cancer has been identified by a research team.
Prostate cancers are either low-grade, low-risk forms that may be monitored but otherwise untreated. Or they're serious enough to require surgery and radiation. Monitoring can cause patients anxiety. Radical treatment comes with complications. For...Show More Summary
A study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center and other institutions found a link between higher intake of dietary saturated fat, a type of fat found commonly in foods such as fatty beef and cheese, and risk of aggressive prostate cancer.
The study - the first trial to publish five-year results from SBRT treatment for prostate cancer - found a 98.6 percent cure rate with SBRT, a noninvasive form of radiation treatment that involves high-dose radiation beams entering the body through various angles and intersecting at the desired target.
DALLAS - April 18, 2016 - A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center. read more
The demand for radiotherapy across all European countries will increase by an average of 16% between 2012 and 2025, with the highest expected increase being for prostate cancer cases (24%), according to a new study published in Radiotherapy...Show More Summary
COLUMBIA, Mo. - Standard treatment for prostate cancer can include chemotherapy that targets receptors on cancer cells. However, drug-resistant cancer cells can emerge during chemotherapy, limiting its effectiveness as a cancer-fighting agent. Show More Summary
Men receiving androgen deprivation therapy for localized prostate cancer have a significantly higher risk of developing depression, according to a new study.
THIS ISN’T SURPRISING, GIVEN THAT TESTOSTERONE IS A POTENT ANTI-DEPRESSANT: Hormone Therapy for Prostate Cancer Tied to Depression. “Compared with those treated with other therapies, men who received androgen deprivation therapy were...Show More Summary
A new study led by researchers at Brigham and Women's Hospital (BWH) has found a significant association between depression and patients being treated for localized prostate cancer (PCa) by androgen deprivation therapy (ADT). The findings are published online in the Journal of Clinical Oncology on April 11, 2016. read more